p53 mutant mice that display early ageing-associated phenotypes
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The p53 tumour suppressor is activated by numerous stressors to induce apoptosis, cell cycle arrest, or senescence. To study the biological effects of altered p53 function, we generated mice with a deletion mutation in the first six exons of the p53 gene that express a truncated RNA capable of encoding a carboxy-terminal p53 fragment. This mutation confers phenotypes consistent with activated p53 rather than inactivated p53. Mutant (p53+/m) mice exhibit enhanced resistance to spontaneous tumours compared with wild-type (p53+/+) littermates. As p53+/m mice age, they display an early onset of phenotypes associated with ageing. These include reduced longevity, osteoporosis, generalized organ atrophy and a diminished stress tolerance. A second line of transgenic mice containing a temperature-sensitive mutant allele of p53 also exhibits early ageing phenotypes. These data suggest that p53 has a role in regulating organismal ageing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, in mice, chronically active p53 both promotes cellular senescence and accelerates aging phenotypes [ 31 , 32 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [32]
In the citing paper
“Cells from these modified mice were more susceptible to both p53-mediated apoptosis (Tyner et al., 2002) and p53-mediated senescence (Maier et al., 2004).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Tyner et al., 2002
In the citing paper
“Evidence for this idea comes from the phenotype of genetically modified mice in which p53 function was enhanced either by low-level expression of an artificially truncated p53 protein (Tyner et al., 2002; Maier et al., 2004) or modest overexpression of a naturally occurring short isoform (Maier et al., 2004).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Tyner et al., 2002
In the citing paper
“Delayed wound healing has been used as measure to characterize the aging phenotype of skin (170).”
From Wound repair and regeneration: Mechanisms, signaling, and translation (2014) · cites this paper as [170]
In the citing paper
“p53 deficiency markedly attenuates the degenerative phenotypes associated with telomere dysfunction, whereas constitutively activated p53 accelerates ageing phenotypes15-18.”
From Telomere dysfunction induces metabolic and mitochondrial compromise (2011) · cites this paper as [18]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Self-citationManipulating the mouse embryo: A laboratory manual
Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460
Ko, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
Manipulating the mouse embryo: A laboratory manual
Johnson, M. (1986) · Trends in Genetics · doi:10.1016/0168-9525(86)90275-1 · Cited by 2,245
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Increased bone formation in osteocalcin-deficient mice
Ducy, P., Desbois, C., Boyce, B., Pinero, G., Story, B., Dunstan, C., Smith, E., Bonadio, J., Goldstein, S., Gundberg, C., et al. (1996) · Nature · doi:10.1038/382448a0 · Cited by 1,725
Self-citationThe p66shc adaptor protein controls oxidative stress response and life span in mammals
Migliaccio, E., Giorgio, M., Mele, S., Pelicci, G., Reboldi, P., Pandolfi, P. P., Lanfrancone, L., & Pelicci, P. G. (1999) · Nature · doi:10.1038/46311 · Cited by 1,712
Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349
Research works printed but not linked: 3
- Arking, R. Biology of Aging 2nd edn 153–250 (Sinauer, Sunderland, Massachusetts, 1998).
- Chuttani, A. & Gilchrest, B. A. in Handbook of Physiology, Section 11: Aging (ed. Masoro, E. J.) 309–324 (Oxford Univ. Press, New York, 1995).
- Muravchik, S. in Clinical Anesthesia 3rd edn (eds Barash, P. G., Cullen, B. F. & Stoelting, R. K.) 1125–1136 (Lippincott-Raven, Philadelphia, 1997).
Cited by
Items 201–300 of 1,000
Porcu, M., & Chiarugi, A. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.12.009 · Cited by 173
Senescence Regulation by the p53 Protein Family
Qian, Y., & Chen, X. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_3 · Cited by 171
Kodama, T., Takehara, T., Hikita, H., Shimizu, S., Shigekawa, M., Tsunematsu, H., Li, W., Miyagi, T., Hosui, A., Tatsumi, T., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44957 · Cited by 171
Aging, tumor suppression and cancer: high wire-act!
Campisi, J. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.09.024 · Cited by 171
“Rather, both mutant mouse strains had a modestly shorter life span and displayed multiple signs of premature aging! Moreover, cells from these mice were more prone to undergo apoptosis (Tyner et al., 2002) or”
BackgroundInfluentialProgrammed Death Phenomena: From Organelle to Organism
SKULACHEV, V. P. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02095.x · Cited by 171
Chen, J., Ruan, H., Ng, S. M., Gao, C., Soo, H. M., Wu, W., Zhang, Z., Wen, Z., Lane, D. P., & Peng, J. (2005) · Genes & Development · doi:10.1101/gad.1366405 · Cited by 170
“In mice expressing an N-terminally truncated fragment of p53 as well as the full-length protein, an accelerated aging phenotype has been reported that seems to be due to excess activation of p53 function (Tyner et al. 2002), whereas in transfection-based systems, such truncated fragments can act as dominantnegative in…”
BackgroundYokoi, T., Fukuo, K., Yasuda, O., Hotta, M., Miyazaki, J., Takemura, Y., Kawamoto, H., Ichijo, H., & Ogihara, T. (2006) · Diabetes · doi:10.2337/db05-1607 · Cited by 169
“Interestingly, modestly overactive p53 is reported to result in shortened life span and appearance of premature senescence, despite conferring extraordinary protection against cancer (31).”
Backgroundp53 Isoforms: An Intracellular Microprocessor?
Khoury, M. P., & Bourdon, J.-C. (2011) · Genes & Cancer · doi:10.1177/1947601911408893 · Cited by 159
MicroRNAs in cancer cell death pathways: Apoptosis and necroptosis
Shirjang, S., Mansoori, B., Asghari, S., Duijf, P. H. G., Mohammadi, A., Gjerstorff, M., & Baradaran, B. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.05.017 · Cited by 167
Limiting the power of p53 through the ubiquitin proteasome pathway
Pant, V., & Lozano, G. (2014) · Genes & Development · doi:10.1101/gad.247452.114 · Cited by 167
“Increased p53 activity has been implicated in aging defects (Tyner et al. 2002).”
BackgroundRapid and tunable method to temporally control gene editing based on conditional Cas9 stabilization
Senturk, S., Shirole, N. H., Nowak, D. G., Corbo, V., Pal, D., Vaughan, A., Tuveson, D. A., Trotman, L. C., Kinney, J. B., & Sordella, R. (2017) · Nature Communications · doi:10.1038/ncomms14370 · Cited by 166
“These methods include the generation of temperature-sensitive mutants 30 , conditional deletion alleles in which a gene of interest is flanked by loxP recombination sites to enable acute gene inactivation on expression of Cre recombinase 31 , and inducible gene knockdown based on shRNA mediated…”
The evolution of senescence from a comparative perspective
Ricklefs, R. E. (2008) · Functional Ecology · doi:10.1111/j.1365-2435.2008.01420.x · Cited by 166
Divide and conquer: nucleotide excision repair battles cancer and ageing
Mitchell, J. R., Hoeijmakers, J. H., & Niedernhofer, L. J. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00018-8 · Cited by 160
“Recently, p53 function has also been connected to ageing [45 ].”
BackgroundInsulin‐like growth factor‐1 regulates the SIRT 1‐p53 pathway in cellular senescence
Tran, D., Bergholz, J., Zhang, H., He, H., Wang, Y., Zhang, Y., Li, Q., Kirkland, J. L., & Xiao, Z. (2014) · Aging Cell · doi:10.1111/acel.12219 · Cited by 161
“These mice exhibit an accelerated aging phenotype, exemplified by kyphosis, osteoporosis, generalized organ atrophy, and diminished stress tolerance (Tyner et al., 2002).”
Backgroundp53 Plays a Role in Mesenchymal Differentiation Programs, in a Cell Fate Dependent Manner
Molchadsky, A., Shats, I., Goldfinger, N., Pevsner-Fischer, M., Olson, M., Rinon, A., Tzahor, E., Lozano, G., Zipori, D., Sarig, R., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003707 · Cited by 161
Revisiting the antagonistic pleiotropy theory of aging: TOR-driven program and quasi-program
Blagosklonny, M. V. (2010) · Cell Cycle · doi:10.4161/cc.9.16.13120 · Cited by 160
mTOR's role in ageing: protein synthesis or autophagy?
Hands, S. L., Proud, C. G., & Wyttenbach, A. (2009) · Aging · doi:10.18632/aging.100070 · Cited by 159
Liu, L., Charville, G. W., Cheung, T. H., Yoo, B., Santos, P. J., Schroeder, M., & Rando, T. A. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.08.019 · Cited by 156
“Although mice harboring constitutively active p53 alleles are resistant to cancer at older age, they have a life span 20%–30% shorter than that of wild-type control mice and exhibit several phenotypes associated with aging (Liu et al., 2010; Tyner et al., 2002).”
p53 is balancing development, differentiation and de-differentiation to assure cancer prevention
Molchadsky, A., Rivlin, N., Brosh, R., Rotter, V., & Sarig, R. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq101 · Cited by 156
The Senescence Markers p16INK4A, p14ARF/p19ARF, and p21 in Organ Development and Homeostasis
Wagner, K.-D., & Wagner, N. (2022) · Cells · doi:10.3390/cells11121966 · Cited by 156
“Different mouse models with activated P53 signaling also showed resistance to cancer development, but decreased the lifespan and premature onset of age-related diseases such as osteoporosis and tissue atrophy [267,268].”
BackgroundSystems biology of ageing and longevity
Kirkwood, T. B. L. (2011) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2010.0275 · Cited by 156
DAF-16/FOXO targets genes that regulate tumor growth in Caenorhabditis elegans
Pinkston-Gosse, J., & Kenyon, C. J. (2007) · Nature Genetics · doi:10.1038/ng.2007.1 · Cited by 172
Does p53 affect organismal aging?
Donehower, L. A. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10104 · Cited by 155
“The critical experiment supporting the telomere hypothesis was the demonstration that ectopic expression of telomerase in pre-senescent human cells leads to an immortal phenotype (Bodnar et al., 1998; Vaziri and Benchimol, 1998; Yang et al., 1999; Stewart and Weinberg, 2000).”
BackgroundSelf-citationGambino, V., De Michele, G., Venezia, O., Migliaccio, P., Dall'Olio, V., Bernard, L., Minardi, S. P., Fazia, M. A. D., Bartoli, D., Servillo, G., et al. (2013) · Aging Cell · doi:10.1111/acel.12060 · Cited by 151
“Cells from these mice are more susceptible to both p53-mediated apoptosis (Tyner et al., 2002) and p53-mediated senescence (Maier et al., 2004), suggesting that enhanced cancer protection comes at the cost of accelerated aging.”
BackgroundVascular cell senescence and vascular aging
Minamino, T., Miyauchi, H., Yoshida, T., Tateno, K., Kunieda, T., & Komuro, I. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2003.11.010 · Cited by 164
“[109] Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H, et al.”
BackgroundTissue-specific differences of p53 inhibition by Mdm2 and Mdm4
Grier, J. D., Xiong, S., Elizondo-Fraire, A. C., Parant, J. M., & Lozano, G. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.1.192-198.2006 · Cited by 149
“Mice heterozygous for the p53 gene that produced a truncated active form of p53 displayed increased resistance to spontaneous tumors and early onset of aging-associated phenotypes (33).”
BackgroundChatoo, W., Abdouh, M., David, J., Champagne, M.-P., Ferreira, J., Rodier, F., & Bernier, G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5303-08.2009 · Cited by 149
Loci influencing blood pressure identified using a cardiovascular gene-centric array
Ganesh, S. K., Tragante, V., Guo, W., Guo, Y., Lanktree, M. B., Smith, E. N., Johnson, T., Castillo, B. A., Barnard, J., Baumert, J., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds555 · Cited by 149
“Mice null for p53 shows a variety of aging-related phenotypes (28).”
BackgroundAge-related hyperkyphosis: update of its potential causes and clinical impacts—narrative review
Roghani, T., Zavieh, M. K., Manshadi, F. D., King, N., & Katzman, W. B. (2016) · Aging Clinical and Experimental Research · doi:10.1007/s40520-016-0617-3 · Cited by 185
“Several animal knockout models results in the development of early senescence associated with specified hyperkyphosis [76, 77].”
BackgroundSultana, Z., Maiti, K., Dedman, L., & Smith, R. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.11.567 · Cited by 162
Kim, K. S., Kang, K. W., Seu, Y. B., Baek, S., & Kim, J.-R. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.11.004 · Cited by 164
NADPH oxidases: key modulators in aging and age-related cardiovascular diseases?
Sahoo, S., Meijles, D. N., & Pagano, P. J. (2016) · Clinical Science · doi:10.1042/cs20150087 · Cited by 146
Smith, N. D., Rubenstein, J. N., Eggener, S. E., & Kozlowski, J. M. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000056085.58221.80 · Cited by 172
Inappropriate p53 activation during development induces features of CHARGE syndrome
Van Nostrand, J. L., Brady, C. A., Jung, H., Fuentes, D. R., Kozak, M. M., Johnson, T. M., Lin, C.-Y., Lin, C.-J., Swiderski, D. L., Vogel, H., et al. (2014) · Nature · doi:10.1038/nature13585 · Cited by 143
Antoch, M. P., Gorbacheva, V. Y., Vykhovanets, O., Toshkov, I. A., Kondratov, R. V., Kondratova, A. A., Lee, C., & Nikitin, A. Y. (2008) · Cell Cycle · doi:10.4161/cc.7.9.5886 · Cited by 144
p53 activates transcription by directing structural shifts in Mediator
Meyer, K. D., Lin, S.-C., Bernecky, C., Gao, Y., & Taatjes, D. J. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1816 · Cited by 144
Suppression of Phosphoinositide 3-Kinase Prevents Cardiac Aging in Mice
Inuzuka, Y., Okuda, J., Kawashima, T., Kato, T., Niizuma, S., Tamaki, Y., Iwanaga, Y., Yoshida, Y., Kosugi, R., Watanabe-Maeda, K., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.871137 · Cited by 144
Ink4a/Arf links senescence and aging
Sharpless, N. E. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.06.025 · Cited by 142
Calcium signaling alterations, oxidative stress, and autophagy in aging
Ureshino, R. P., Rocha, K. K., Lopes, G. S., Bincoletto, C., & Smaili, S. S. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5777 · Cited by 143
ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence
Ha, L., Ichikawa, T., Anver, M., Dickins, R., Lowe, S., Sharpless, N. E., Krimpenfort, P., DePinho, R. A., Bennett, D. C., Sviderskaya, E. V., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611638104 · Cited by 143
Gogiraju, R., Xu, X., Bochenek, M. L., Steinbrecher, J. H., Lehnart, S. E., Wenzel, P., Kessel, M., Zeisberg, E. M., Dobbelstein, M., & Schäfer, K. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.001770 · Cited by 143
“For example, prolonged passaging (mimicking senescence) of human vein endothelial cells was associated with p53 accumulation,(45) whereas mice with a truncated p53 mutation resulting in p53 activation exhibited an early-onset phenotype consistent with accelerated aging.(46)”
BackgroundJin, H., Lian, N., Zhang, F., Chen, L., Chen, Q., Lu, C., Bian, M., Shao, J., Wu, L., & Zheng, S. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.92 · Cited by 143
“dence has shown that the tumor suppressor P53 can regulate cellular senescence.(12) The P53 can lead to cell cycle arrest,”
BackgroundAdult-onset, short-term dietary restriction reduces cell senescence in mice
Wang, C., Maddick, M., Miwa, S., Jurk, D., Czapiewski, R., Saretzki, G., Langie, S. A. S., Godschalk, R. W. L., Cameron, K., & von Zglinicki, T. (2010) · Aging · doi:10.18632/aging.100196 · Cited by 142
“High frequencies of senescent cells have been associated with age-related diseases like osteoarthritis and atherosclerosis [29,30] and were also found in mouse models of accelerated aging [31-34].”
BackgroundGenetics of Longevity and Aging
Vijg, J., & Suh, Y. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104617 · Cited by 142
Genome stability and the processing of damaged replication forks by RecG
McGlynn, P., & Lloyd, R. G. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02720-8 · Cited by 157
Human Sir2 and the ‘silencing’ of p53 activity
Smith, J. S. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(02)02342-5 · Cited by 152
The Posttranslational Processing of Prelamin A and Disease
Davies, B. S. J., Fong, L. G., Yang, S. H., Coffinier, C., & Young, S. G. (2009) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082908-150150 · Cited by 141
“The disease phenotypes of ZMPSTE24 deficiency appeared to be partially ameliorated by homozygous loss of p53, a result that is consistent with the notion that p53 is activated in aging (99).”
Semaphorin3E-Induced Inflammation Contributes to Insulin Resistance in Dietary Obesity
Shimizu, I., Yoshida, Y., Moriya, J., Nojima, A., Uemura, A., Kobayashi, Y., & Minamino, T. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.09.001 · Cited by 154
“, 2007) and that a low level of constitutive p53 activation leads to premature aging in mice (Maier et al., 2004; Tyner et al., 2002).”
BackgroundThe pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor
Renault, V. M., Thekkat, P. U., Hoang, K. L., White, J. L., Brady, C. A., Kenzelmann Broz, D., Venturelli, O. S., Johnson, T. M., Oskoui, P. R., Xuan, Z., et al. (2011) · Oncogene · doi:10.1038/onc.2011.35 · Cited by 138
The role of adipose tissue senescence in obesity- and ageing-related metabolic disorders
Liu, Z., Wu, K. K. L., Jiang, X., Xu, A., & Cheng, K. K. Y. (2020) · Clinical Science · doi:10.1042/cs20190966 · Cited by 137
Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging
Matheu, A., Pantoja, C., Efeyan, A., Criado, L. M., Martín-Caballero, J., Flores, J. M., Klatt, P., & Serrano, M. (2004) · Genes & Development · doi:10.1101/gad.310304 · Cited by 138
The p53 network in lung carcinogenesis
Robles, A. I., Linke, S. P., & Harris, C. C. (2002) · Oncogene · doi:10.1038/sj.onc.1205563 · Cited by 154
“This senescence-associated activity of p53 can be modulated by PML and p33ING1 (Pearson et al., 2000; Garkavtsev and Riabowol, 1997), and recent data on genetically engineered mice suggests that chronically active p53 leads to premature ageing (Tyner et al., 2002).”
BackgroundAlmeida, M. (2012) · BoneKEy Reports · doi:10.1038/bonekey.2012.102 · Cited by 136
Toufektchan, E., & Toledo, F. (2018) · Cancers · doi:10.3390/cancers10050135 · Cited by 134
“However, the mice have a surprisingly reduced lifespan correlating with features of accelerated aging [100,101].”
BackgroundBalancing regeneration and cancer
Beausejour, C. M., & Campisi, J. (2006) · Nature · doi:10.1038/nature05221 · Cited by 147
Coşkun, S., Chao, H., Vasavada, H., Heydari, K., Gonzales, N., Zhou, X., de Crombrugghe, B., & Hirschi, K. K. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.09.013 · Cited by 133
“constitutive expression of p53 results in exhaustion of the adult HSC pool and premature aging (Tyner et al., 2002).”
BackgroundCabelof, D. C. (2003) · DNA repair · doi:10.1016/s1568-7864(02)00219-7 · Cited by 133
“[42]”
Skin Adipocyte Stem Cell Self-Renewal Is Regulated by a PDGFA/AKT-Signaling Axis
Rivera-Gonzalez, G. C., Shook, B. A., Andrae, J., Holtrup, B., Bollag, K., Betsholtz, C., Rodeheffer, M. S., & Horsley, V. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.09.002 · Cited by 131
“Although adipocyte hyperplasia occurs in several depots during obesity (Jeffery et al., 2015; Vishvanath et al., 2016) and regenerative processes in the skin (Festa et al., 2011), the cellular and molecular mechanisms that regulate adipocyte hyperplasia and maintenance are not well understood.”
BackgroundKado, D. M., Huang, M., Barrett-Connor, E. L., & Greendale, G. A. (2005) · The Journals of Gerontology Series A · doi:10.1093/gerona/60.5.633 · Cited by 150
WIP1 phosphatase at the crossroads of cancer and aging
Guezennec, X. L., & Bulavin, D. V. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.09.005 · Cited by 147
Regulation of glucose metabolism by p53: Emerging new roles for the tumor suppressor
Madan, E., Gogna, R., Bhatt, M., Pati, U., Kuppusamy, P., & Mahdi, A. A. (2011) · Oncotarget · doi:10.18632/oncotarget.389 · Cited by 131
“However, such programmed mice show signs of premature aging [72, 73].”
BackgroundPARDAL, R., MOLOFSKY, A. V., HE, S., & MORRISON, S. J. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.057 · Cited by 131
“Mice expressing a mutant form of p53 that augments wild-type p53 activity exhibit enhanced resistance to spontaneous tumors and display an early onset of phenotypes associated with aging (Tyner et al. 2002).”
Backgroundp21 Both Attenuates and Drives Senescence and Aging in BubR1 Progeroid Mice
Baker, D. J., Weaver, R. L., & van Deursen, J. M. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.03.028 · Cited by 130
“…such as Zmpste24 null (a model for Hutchinson-Gilford progeria), Brca1 null, and Ercc1 hypomorphic mice, showing that p53 drives early aging in these models (Cao et al., 2003; Kirkwood, 2002; Maier et al., 2004; Núñez et al., 2000; Sharpless, 2004; Tyner et al., 2002; Varela et al., 2005).”
Maclaine, N. J., & Hupp, T. R. (2009) · Aging · doi:10.18632/aging.100047 · Cited by 130
“These animals exhibited aging phenotypes including reduced longevity, osteoporosis, generalized organ atrophy and a diminished stress tolerance [7].”
BackgroundAtrx deficiency induces telomere dysfunction, endocrine defects, and reduced life span
Watson, L. A., Solomon, L. A., Li, J. R., Jiang, Y., Edwards, M., Shin-ya, K., Beier, F., & Bérubé, N. G. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65634 · Cited by 130
“Hyperactivity of the p53 tumor suppressor gene shortens life span and accelerates aging in mice (67).”
Lanni, C., Masi, M., Racchi, M., & Govoni, S. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0760-2 · Cited by 130
“disorders, including AD [103–108], as an increased rate in its activity is correlated with organism aging and senescence establishment [109, 110].”
BackgroundThe p53 pathway in hematopoiesis: lessons from mouse models, implications for humans
Pant, V., Quintás-Cardama, A., & Lozano, G. (2012) · Blood · doi:10.1182/blood-2012-05-356014 · Cited by 129
Genome-Wide Analysis of Survival in Early-Stage Non–Small-Cell Lung Cancer
Huang, Y., Heist, R. S., Chirieac, L. R., Lin, X., Skaug, V., Zienolddiny, S., Haugen, A., Wu, M. C., Wang, Z., Su, L., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.7906 · Cited by 141
“The dual and opposite role in life span by mechanisms of cellular senescence/aging and tumor suppression has also been shown in tumor suppressor genes p53 and p16.(27,28) However, further investigation is needed to disentangle true but opposite associations from the chance associations.”
BackgroundGenome instability, cancer and aging
Maslov, A. Y., & Vijg, J. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.03.020 · Cited by 128
“An example of such a model is the p53+/m mouse generated in the Donehower laboratory [63].”
MethodKaul, S. C., Aida, S., Yaguchi, T., Kaur, K., & Wadhwa, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500022200 · Cited by 138
Inhibiting S100B Restores p53 Levels in Primary Malignant Melanoma Cancer Cells
Lin, J., Yang, Q., Yan, Z., Markowitz, J., Wilder, P. T., Carrier, F., & Weber, D. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405419200 · Cited by 137
The Arf/p53 pathway in cancer and aging
Matheu, A., Maraver, A., & Serrano, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6851 · Cited by 105
“Two mouse models have unveiled a proaging activity ofp53 ( 12 , 13).”
BackgroundActivation of p53 by nutlin leads to rapid differentiation of human embryonic stem cells
Maimets, T., Neganova, I. E., Armstrong, L., & Lako, M. (2008) · Oncogene · doi:10.1038/onc.2008.166 · Cited by 132
Shibuya, S., Ozawa, Y., Watanabe, K., Izuo, N., Toda, T., Yokote, K., & Shimizu, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109288 · Cited by 127
Xiong, H., Pang, J., Yang, H., Dai, M., Liu, Y., Ou, Y., Huang, Q., Chen, S., Zhang, Z., Xu, Y., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.12.034 · Cited by 134
Peto’s Paradox: how has evolution solved the problem of cancer prevention?
Tollis, M., Boddy, A. M., & Maley, C. C. (2017) · BMC Biology · doi:10.1186/s12915-017-0401-7 · Cited by 88
“For instance, it was found that genetically altering mice to overexpress a form of the TP53 protein conferred a cancer-suppressive phenotype; however, these mice also displayed a premature ageing phenotype [18].”
BackgroundControl of cell migration: a tumour suppressor function for p53?
Roger, L., Gadea, G., & Roux, P. (2006) · Biology of the Cell · doi:10.1042/bc20050058 · Cited by 126
“…from the wound edge, therefore supporting the potential role of p53 in regulating physiological processes of tissue regeneration in vivo (Tyner et al., 2002). p53 inhibits cell spreading The spreading of cells on a matrix is a major event that is necessary to engage (commit) cells in a…”
BackgroundClassic and novel roles of p53: prospects for anticancer therapy
Fuster, J. J., Sanz-Gonzalez, S. M., Moll, U. M., & Andrés, V. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.03.002 · Cited by 141
Therapeutic exploitation of the p53 pathway
Lane, D. P., & Laín, S. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02309-2 · Cited by 139
Expansion of hematopoietic stem cell phenotype and activity in Trp53-null mice
TeKippe, M., Harrison, D. E., & Chen, J. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00072-9 · Cited by 145
Stress-induced Premature Senescence (SIPS)
SUZUKI, M., & BOOTHMAN, D. A. (2008) · Journal of Radiation Research · doi:10.1269/jrr.07081 · Cited by 126
Sex-specific regulation of aging and apoptosis
Tower, J. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.05.001 · Cited by 125
“Importantly, a key regulator of mitochondrial-dependent apoptosis pathways, p53, is implicated in life span regulation in Drosophila, mice and humans (Tyner et al., 2002; Gaspari et al., 2003; Maier et al., 2004; Bauer et al., 2005; van Heemst et al., 2005; Gatza et al., 2006).”
BackgroundVascular ageing and endothelial cell senescence: Molecular mechanisms of physiology and diseases
Regina, C., Panatta, E., Candi, E., Melino, G., Amelio, I., Balistreri, C. R., Annicchiarico-Petruzzelli, M., Di Daniele, N., & Ruvolo, G. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.05.003 · Cited by 122
The Red Sea, Coastal Landscapes, and Hominin Dispersals
Bailey, G. N. (2009) · Vertebrate paleobiology and paleoanthroplogy series/Vertebrate paleobiology and paleoanthropology series · doi:10.1007/978-90-481-2719-1_2 · Cited by 151
MicroRNA Regulation of Oxidative Stress‐Induced Cellular Senescence
Bu, H., Wedel, S., Cavinato, M., & Jansen-Dürr, P. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2398696 · Cited by 122
“p53 mutant mice with consistent active p53 showed diminished stress tolerance and reduced lifespan [27, 28], while mouse with increased but otherwise normally regulated p53 showed a normal aging [29, 30].”
BackgroundWhat evidence is there for the existence of individual genes with antagonistic pleiotropic effects?
Leroi, A. M., Bartke, A., Benedictis, G. D., Franceschi, C., Gartner, A., Gonos, E. S., Feder, M. E., Kivisild, T., Lee, S. Y., Özer, N. K., et al. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.07.012 · Cited by 136
“Mice heterozygous for an activating mutation in p53 have increased resistance to tumours but show premature ageing: reduced longevity, osteoporosis, organ atrophy and diminished stress tolerance (Tyner et al., 2002).”
BackgroundMuscle cachexia is regulated by a p53–PW1/Peg3-dependent pathway
Schwarzkopf, M., Coletti, D., Sassoon, D., & Marazzi, G. (2006) · Genes & Development · doi:10.1101/gad.412606 · Cited by 122
“Since p53−/− mice develop tumors between 3 and 6 mo of age (Donehower et al. 1992; Jacks et al. 1994; Tyner et al. 2002), we used young (7 wk) mice that were analyzed at 10 wk of age—well before the onset of spontaneous tumor occurrence.”
BackgroundMethodp53-Dependent ICAM-1 overexpression in senescent human cells identified in atherosclerotic lesions
Gorgoulis, V. G., Pratsinis, H., Zacharatos, P., Demoliou, C., Sigala, F., Asimacopoulos, P. J., Papavassiliou, A. G., & Kletsas, D. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700241 · Cited by 122
“20 Moreover, mice that express a modestly hyperactive p53 form display a premature onset of a spectrum of age-related features and reduced longevity, hence implicating p53 also in organismal aging”
BackgroundØrsted, D. D., Bojesen, S. E., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062476 · Cited by 122
Nuclear DNA Damage as a Direct Cause of Aging
Best, B. P. (2009) · Rejuvenation Research · doi:10.1089/rej.2009.0847 · Cited by 122
Impaired SIRT1 nucleocytoplasmic shuttling in the senescent heart during ischemic stress
Tong, C., Morrison, A., Mattison, S., Qian, S., Bryniarski, M., Rankin, B., Wang, J., Thomas, D. P., & Li, J. (2013) · The FASEB Journal · doi:10.1096/fj.12-216473 · Cited by 121
Sirt7 promotes adipogenesis in the mouse by inhibiting autocatalytic activation of Sirt1
Fang, J. C., Ianni, A., Smolka, C., Vakhrusheva, O., Nolte, H., Krüger, M., Wietelmann, A., Simonet, N. G., Adrian-Segarra, J. M., Vaquero, A., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706945114 · Cited by 133
“Most significantly, p53 hypomorphic mice develop lipodystrophy during aging, which strongly resembles the phenotype of Sirt7deficient mice (44).”
BackgroundAtherothrombosis and Oxidative Stress: Mechanisms and Management in Elderly
Violi, F., Loffredo, L., Carnevale, R., Pignatelli, P., & Pastori, D. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6963 · Cited by 118
“The role of p53 in premature aging has been demonstrated by several mouse models where persistent p53 activation promoted senescence or irreversible cell cycle arrest (372).”
p53: emerging roles in stem cells, development and beyond
Jain, A. K., & Barton, M. C. (2018) · Development · doi:10.1242/dev.158360 · Cited by 119
“…apoptosis to include the regulation of cellular homeostasis and metabolism (Gottlieb and Vousden, 2010), inflammation (Cooks et al., 2014), reproduction (Hu et al., 2007; Levine et al., 2011), ageing (Tyner et al., 2002a), regeneration (Pomerantz and Blau, 2013) and more (Vousden and Prives, 2009).”
BackgroundWang, L., Yang, L., Debidda, M., Witte, D., & Zheng, Y. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609149104 · Cited by 119
A new model for the evolution of the human Pleistocene populations of Europe
de Castro, J. M. B., & Martinón‐Torres, M. (2012) · Quaternary International · doi:10.1016/j.quaint.2012.02.036 · Cited by 134
SIRT1-FOXOs activity regulates diabetic complications
Jalgaonkar, M. P., Parmar, U. M., Kulkarni, Y. A., & Oza, M. J. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.106014 · Cited by 121
The nucleolus as a fundamental regulator of the p53 response and a new target for cancer therapy
Woods, S. J., Hannan, K. M., Pearson, R. B., & Hannan, R. D. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.10.007 · Cited by 128
Genes encoding longevity: from model organisms to humans
Kuningas, M., Mooijaart, S. P., van Heemst, D., Zwaan, B. J., Slagboom, P. E., & Westendorp, R. G. J. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00366.x · Cited by 124
Noncoding RNA in age-related cardiovascular diseases
Greco, S., Gorospe, M., & Martelli, F. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.01.011 · Cited by 120
“Accordingly, restoring Mhrt prevented heart hypertrophy and failure, indicating that Mhrt has a protective role in CVDs [132].”
BackgroundInfluential
Metadata
- Authors
- Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., Hee Park, S., Thompson, T., Karsenty, G., Bradley, A., & Donehower, L. A.
- Affiliations
- Baylor College of Medicine (US)
- University of Massachusetts Chan Medical School (US)
- Leibniz Institute of Virology (LIV) (DE)
- Wellcome Sanger Institute (GB)
- Corresponding author
- Donehower, Lawrence A.
- Venue
- Nature
- Published
- 2002-01
- Volume
- 415
- Issue
- 6867
- Pages
- 45-53
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2171317581
- Cited by
- 1,459
- References
- 42
- Citations by year
- 2026: 20 · 2025: 19 · 2024: 17 · 2023: 41 · 2022: 30 · 2021: 45 · 2020: 36 · 2019: 37 · 2018: 45 · 2017: 49 · 2016: 52 · 2015: 52 · 2014: 60 · 2013: 64 · 2012: 69
- FWCI
- 27.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- p53, aging, longevity, osteoporosis, organ atrophy, stress tolerance, transgenic mice, apoptosis, cellular senescence
- MeSH terms
- Adipose Tissue, Aging, Alleles, Animals, Body Weight, Bone and Bones, Cell Transformation, Neoplastic, Cells, Cultured, Exons, Female, Hair, Longevity, Male, Mice, Transgenic, Neoplasms, Organ Size, Osteoporosis, Phenotype, RNA, Messenger, Skin, Wound Healing, Genes, p53, Tumor Suppressor Protein p53, Sequence Deletion, Aging, Premature, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.